Man raises the price of lifesaving drug by over 5000% after buying it’s rights

Medical organizations protested loudly on Sunday after a company owned by controversial former hedge fund manager Martin Shkreli raised the price of the drug Daraprim, which treats a dangerous parasitic infection, from $13.50 per pill to 
$750 per pill. .

Daraprim ( Pyrimethamine ) is commonly used as an antimalarial drug and also used in the management of HIV-positive individuals. It is on WHO’s List of Essential Medicines, the most important medications needed in a basic health system. Shkreli’s startup company, Turing Pharmaceuticals, acquired Daraprim in August.